Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2.2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 14 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 50 business days late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays.
The 39 most recent Form 4 transactions.
| Jul 24 | APGE | Apogee Therapeutics, Inc. | GGIFT | 15,000 | — | — | -8.6% | Open the original filing on SEC.gov |
| May 1 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 289 | $83.16 | $24K | -0.2% | Open the original filing on SEC.gov |
| May 1 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 900 | $82.60 | $74.3K | -0.5% | Open the original filing on SEC.gov |
| May 1 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 811 | $81.02 | $65.7K | -0.5% | Open the original filing on SEC.gov |
| Apr 16 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 2,000 | $90.00 | $180K | -1.1% | Open the original filing on SEC.gov |
| Apr 1 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 1,100 | $85.46 | $94K | -0.6% | Open the original filing on SEC.gov |
| Apr 1 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 900 | $84.46 | $76K | -0.5% | Open the original filing on SEC.gov |
| Mar 25 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 2,000 | $85.00 | $170K | -1.1% | Open the original filing on SEC.gov |
| Mar 2 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 406 | $71.66 | $29.1K | -0.2% | Open the original filing on SEC.gov |
| Mar 2 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 994 | $70.45 | $70K | -0.5% | Open the original filing on SEC.gov |
| Mar 2 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 300 | $69.43 | $20.8K | -0.2% | Open the original filing on SEC.gov |
| Mar 2 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 300 | $68.27 | $20.5K | -0.2% | Open the original filing on SEC.gov |
| Feb 2 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 100 | $66.89 | $6.7K | <0.1% | Open the original filing on SEC.gov |
| Feb 2 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 1,108 | $66.15 | $73.3K | -0.6% | Open the original filing on SEC.gov |
| Feb 2 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 792 | $65.21 | $51.6K | -0.4% | Open the original filing on SEC.gov |
| Jan 6 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 2,000 | $80.00 | $160K | -1.1% | Open the original filing on SEC.gov |
| Jan 2 | APGE | Apogee Therapeutics, Inc. | AGRANT◷◆ | 83,690 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 4,080 | $75.20 | $306.8K | -2.1% | Open the original filing on SEC.gov |
| Jan 2 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 1,920 | $74.13 | $142.3K | -1.0% | Open the original filing on SEC.gov |
| Dec 19, 2025 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 1,500 | $80.00 | $120K | -0.8% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 11,797 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 13,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 13,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 26,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 9,398 | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 4, 2025 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 1,500 | $75.00 | $112.5K | -0.8% | Open the original filing on SEC.gov |
| Nov 25, 2025 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 1,500 | $70.00 | $105K | -0.8% | Open the original filing on SEC.gov |
| Nov 14, 2025 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 2,000 | $65.00 | $130K | -1.0% | Open the original filing on SEC.gov |
| Nov 11, 2025 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 1,000 | $60.00 | $60K | -0.5% | Open the original filing on SEC.gov |
| Aug 19, 2025 | CRGX | CARGO Therapeutics, Inc. | DTOISS◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 12, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 12, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL | 3,000 | $47.46 | $142.4K | -24.2% | Open the original filing on SEC.gov |
| Aug 12, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 3,000 | $7.01 | $21K | +31.9% | Open the original filing on SEC.gov |
| Jun 18, 2025 | CRGX | CARGO Therapeutics, Inc. | AGRANT◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 3, 2025 | AKRO | Akero Therapeutics, Inc. | AGRANT | 9,398 | — | — | — | Open the original filing on SEC.gov |